For: |
Wang Y, Wei L, Jiang D, Cong X, Fei R, Xiao J, Wang Y. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i5/649.htm |
Number | Citing Articles |
1 |
Rong-Juan Pei, Xin-Wen Chen, Meng-Ji Lu. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. World Journal of Gastroenterology 2014; 20(33): 11618-11629 doi: 10.3748/wjg.v20.i33.11618
|
2 |
X. B. Pan, L. Wei, H. S. Chen, F. Liu, Y. Gao. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns. Archives of Virology 2007; 152(6): 1159 doi: 10.1007/s00705-006-0927-4
|
3 |
L. J. Liu, J. H. Wang, S. C. Du, J. H. Tian, R. F. Yang, L. Wei. rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B. Journal of Viral Hepatitis 2010; 17(s1): 66 doi: 10.1111/j.1365-2893.2010.01273.x
|
4 |
M. A. Aslam, F. R. Awan, I. Tauseef, S. Ali, N. Ahmad, N. A. Malik, M. N. Riaz, J. A. Qureshi. Identification of hepatitis B virus core mutants by PCR-RFLP in chronic hepatitis B patients from Punjab, Pakistan. Archives of Virology 2008; 153(1): 163 doi: 10.1007/s00705-007-1093-z
|
5 |
Jianghua Wang, Haiying Zhang, Yingjun Zhang, Dong Jiang, Jing Li, Siegfried Goldmann, Qingyun Ren, Ran Fei, Xueyan Wang, Lai Wei. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein. Journal of Medical Virology 2017; 89(10): 1804 doi: 10.1002/jmv.24830
|
6 |
Max Q. Arens, Ella M. Swierkosz. Clinical Virology Manual. 2009; : 134 doi: 10.1128/9781555815974.ch12
|
7 |
Mengxin Lin, Ruyi Guo, Cuiping Ma, Dawu Zeng, Zhijun Su. Manganese Breaks the Immune Tolerance of HBs-Ag. Open Forum Infectious Diseases 2021; 8(2) doi: 10.1093/ofid/ofab028
|
8 |
Lidan Hou, Jie Zhao, Liuxin Cai, Ling Jin, Boqiang Liu, Shijie Li, Jin Yang, Tong Ji, Songyi Li, Liang Shi, Bo Shen, Hong Yu, Yifan Wang, Xiujun Cai. HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase. Journal of Medical Virology 2024; 96(4) doi: 10.1002/jmv.29607
|
9 |
Hui Ma, Xing-Liang Zhao, Xue-Yan Wang, Xing-Wang Xie, Jin-Chao Han, Wen-Li Guan, Qin Wang, Lin Zhu, Xiao-Ben Pan, Lai Wei, Wenyu Lin. 2’,3’-Cyclic Nucleotide 3’-Phosphodiesterases Inhibit Hepatitis B Virus Replication. PLoS ONE 2013; 8(11): e80769 doi: 10.1371/journal.pone.0080769
|
10 |
Max Q. Arens, Ella M. Swierkosz. Manual of Clinical Microbiology. 2011; : 1729 doi: 10.1128/9781555816728.ch110
|
11 |
Quan Zhang, Yan Wang, Lai Wei, Dong Jiang, Jiang Hua Wang, Hui Ying Rao, Ling Zhu, Hongsong Chen, Ran Fei, Xu Cong. Role of ISGF3 in modulating the anti‐hepatitis B virus activity of interferon‐alpha in vitro. Journal of Gastroenterology and Hepatology 2008; 23(11): 1747 doi: 10.1111/j.1440-1746.2007.04985.x
|
12 |
Huguang Chen, Shuya Luo, Weili Lu, Zhi Chen, Jiamin Chen, Shu Zheng, Jiekai Yu. Serum protein expression patterns in detecting a new viral protein in HBeAg‐negative chronic hepatitis B. Journal of Viral Hepatitis 2019; 26(S1): 90 doi: 10.1111/jvh.13166
|
13 |
Yanan Guo, He Lu, Lei Xu, Nur Fazleen Binti Idris, Yimin Li, Jieli Hu, Ailong Huang, Zeng TU. The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element. Medicine 2019; 98(51): e18442 doi: 10.1097/MD.0000000000018442
|
14 |
Lawrence Ehis Okoror, Ayodele Oluwaseun Ajayi, Oluwaseun Benjamin Ijalana. Elevated serum β2-microglobulin in individuals coinfected with hepatitis B and hepatitis D virus in a rural settings in Southwest Nigeria. BMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-3015-9
|
15 |
Jia-Jie Lu, En-Qiang Chen, Jia-Hong Yang, Tao-You Zhou, Li Liu, Hong Tang. A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-10
|
16 |
Xue-Yan Wang, Zhen-Man Wei, Guo-Yi Wu, Jiang-Hua Wang, Ying-Jun Zhang, Jing Li, Heng-Hui Zhang, Xing-Wang Xie, Xian Wang, Zhao-He Wang, Lai Wei, Yu Wang, Hong-Song Chen. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations. Antiviral Therapy 2012; 17(5): 793 doi: 10.3851/IMP2152
|
17 |
Stephen Locarnini, William S. Mason. Cellular and virological mechanisms of HBV drug resistance. Journal of Hepatology 2006; 44(2): 422 doi: 10.1016/j.jhep.2005.11.036
|